latest health care news

26.11.18

NHS to save record £300m on biosimilar drugs deal

The NHS is set to make its biggest saving from a single drug negotiation in its history after negotiating deals on low cost versions of its most expensive drug.

As announced by Simon Stevens today, the NHS has negotiated deals with five manufactures for ‘biosimilar’ versions of adalimumab which will save £300m for the health service.

The figure is double the previous estimates and is enough to pay for 11,700 community nurses, or 19,800 breast cancer treatments.

The deal means that hospitals should pay around a quarter of the £400m they currently spend on adalimumab which is used to treat severe hospital treated conditions such as rheumatoid arthritis and inflammatory bowel disease.

NHS England’s chief executive said: “Harnessing the power of competition between drug companies, NHS England has now freed up hundreds of millions of pounds of savings to reinvest in patient care.

“By working with patients and frontline clinicians, we’ve now successfully negotiated the biggest ever set of savings on what was the NHS’s most costly drug.

He said this was part of the NHS’s long-term plan of ensuring every penny of investment is “wisely spent.”

“This is another example of how the smarter approach to biosimilar medicines in the UK and Europe gives patients and taxpayers a much better deal than they get in the United States.”

NHS England accepted bids from four companies who manufacture biosimilar versions of the medicine alongside the original supplier, and this will mean it is on course to deliver its ambition to cut £300m from the nation’s annual medicines bill by 2021.

More than 46,000 patients are currently being prescribed the drug, and biosimilar versions are expected to be available from December.

NHS England has issued guidance to trusts and CCGs telling them that nine out of 10 patients should be started on the best value medicine following the launch.

Image credit - sturti

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

featured articles

View all News

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

health service focus

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

interviews

Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

24/10/2019Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

Today, speaking at the Royal College of General Practitioners (RCGP) annual... more >

the scalpel's daily blog

Calling the NHS a ‘Covid-only service’ is untrue, unfair and potentially dangerous

12/08/2020Calling the NHS a ‘Covid-only service’ is untrue, unfair and potentially dangerous

Chris Hopson, Chief Executive, NHS Providers Last week the NHS was widely described as providing a ‘Covid-19 only’ service for much of the last few months. Fr... more >
read more blog posts from 'the scalpel' >